These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26630153)

  • 1. Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count.
    Skogmar S; Schön T; Balcha TT; Sturegård E; Jansson M; Björkman P
    PLoS One; 2015; 10(12):e0144292. PubMed ID: 26630153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neopterin levels in HIV infected patients with & without tuberculosis.
    Immanuel C; Victor L; Chelvi KS; Padmapriyadarsini C; Rehman F; Iliayas S; Swaminathan S
    Indian J Med Res; 2005 Apr; 121(4):220-5. PubMed ID: 15817939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia.
    Skogmar S; Schön T; Balcha TT; Jemal ZH; Tibesso G; Björk J; Björkman P
    PLoS One; 2013; 8(12):e83270. PubMed ID: 24358268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.
    Tan HY; Yong YK; Andrade BB; Shankar EM; Ponnampalavanar S; Omar SF; Narendran G; Kamarulzaman A; Swaminathan S; Sereti I; Crowe SM; French MA
    AIDS; 2015 Feb; 29(4):421-31. PubMed ID: 25565499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.
    Wanchu A; Bhatnagar A; Khullar M; Sud A; Bambery P; Singh S
    BMC Infect Dis; 2002 Jul; 2():15. PubMed ID: 12147177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy.
    Kurz K; Teerlink T; Sarcletti M; Weiss G; Zangerle R; Fuchs D
    Antivir Ther; 2012; 17(6):1021-7. PubMed ID: 22892398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.
    Wejse C; Furtado A; Camara C; Lüneborg-Nielsen M; Sodemann M; Gerstoft J; Katzenstein TL
    Int J Infect Dis; 2013 Oct; 17(10):e907-12. PubMed ID: 23816410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
    Chaisson LH; Semitala FC; Asege L; Mwebe S; Katende J; Nakaye M; Andama AO; Marquez C; Atuhumuza E; Kamya M; Cattamanchi A; Yoon C
    AIDS; 2019 Apr; 33(5):895-902. PubMed ID: 30649057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in beta-2 microglobulin levels after antitubercular therapy in tubercular patients with HIV infection.
    Wanchu A; Arora S; Bhatnagar A; Sud A; Bambery P; Singh S
    Indian J Chest Dis Allied Sci; 2001; 43(4):211-5. PubMed ID: 18610664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Virus Affects Tuberculosis-Specific T Cells in HIV-Negative Patients.
    El-Mokhtar MA; Elgendy SG; Eldin AS; Hassan EA; Hasan AAA; Abdel Hameed MR; Sayed D; Salama EH
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31952232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia.
    Wondmagegn T; Damtie D; Genetu M; Biadgo B; Lemma M; Negash M
    BMC Infect Dis; 2020 Feb; 20(1):109. PubMed ID: 32033581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
    Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
    Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis.
    Hanna LE; Nayak K; Subramanyam S; Venkatesan P; Narayanan PR; Swaminathan S
    Indian J Med Res; 2009 May; 129(5):548-54. PubMed ID: 19675383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between HIV Coinfection, Interleukin 10 Production, and Mycobacterium tuberculosis in Human Lymph Node Granulomas.
    Diedrich CR; O'Hern J; Gutierrez MG; Allie N; Papier P; Meintjes G; Coussens AK; Wainwright H; Wilkinson RJ
    J Infect Dis; 2016 Nov; 214(9):1309-1318. PubMed ID: 27462092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchy Low CD4+/CD8+ T-Cell Counts and IFN-γ Responses in HIV-1+ Individuals Correlate with Active TB and/or M.tb Co-Infection.
    Shao L; Zhang X; Gao Y; Xu Y; Zhang S; Yu S; Weng X; Shen H; Chen ZW; Jiang W; Zhang W
    PLoS One; 2016; 11(3):e0150941. PubMed ID: 26959228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Matricellular Protein Levels in Blood Predict Recovery in Patients with Human Immunodeficiency Virus-Tuberculosis Coinfection.
    Shete A; Ghate M; Iwasaki-Hozumi H; Patil S; Shidhaye P; Bai G; Matsuba T; Pharande P; Mahajan B; Randive A; Mukherjee A; Hattori T
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis specific responses following therapy for TB: Impact of HIV co-infection.
    Siddiqui S; Sarro Y; Diarra B; Diallo H; Guindo O; Dabitao D; Tall M; Hammond A; Kassambara H; Goita D; Dembele P; Traore B; Hengel R; Nason M; Warfield J; Washington J; Polis M; Diallo S; Dao S; Koita O; Lane HC; Catalfamo M; Tounkara A
    Clin Immunol; 2015 Jul; 159(1):1-12. PubMed ID: 25889622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
    Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
    Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.
    Mugusi SF; Ngaimisi E; Janabi MY; Mugusi FM; Minzi OM; Sasi PG; Bakari M; Lindquist L; Aklillu E; Sandstrom EG
    Antivir Ther; 2012; 17(2):265-74. PubMed ID: 22293579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.